-+ 0.00%
-+ 0.00%
-+ 0.00%

OPUS GENETICS ANNOUNCES INITIAL CLINICAL DATA FROM PHASE 1/2 OPGX-BEST1 GENE THERAPY STUDY AT THE MACULA SOCIETY ANNUAL MEETING

Reuters·02/27/2026 15:10:00

Please log in to view news